Literature DB >> 10716677

Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper.

E Carty1, M De Brabander, R M Feakins, D S Rampton.   

Abstract

BACKGROUND: Excessive mucosal generation of cytokines and eicosanoids has been reported in vitro in ulcerative colitis (UC) using traumatising biopsy techniques, and in vivo using time consuming rectal dialysis. AIMS: To validate a simple filter paper technique to profile rectal mucosal production of cytokines and eicosanoids in vivo in patients with UC compared with controls. PATIENTS: Forty one patients with UC (21 with active disease) and 16 controls were studied.
METHODS: In vitro, recovery of known concentrations of cytokine or mediator applied to filter papers was measured by ELISA following incubation in buffer. In vivo, patients and controls had filter papers apposed to the rectal mucosa briefly through a rigid sigmoidoscope. Filter papers were then incubated prior to assay by ELISA.
RESULTS: In vitro validation studies showed that the filter paper technique could be used to measure mucosal release of interleukin-1beta (IL-1beta), tumour necrosis factor alpha (TNF-alpha), thromboxane B(2) (TXB(2)), and prostaglandin E(2) (PGE(2)), but not interferon gamma (IFN-gamma). Mucosal release of IL-1beta, TNF-alpha, TXB(2) and PGE(2) were significantly increased in active UC (p=0.001) and correlated directly with disease activity (p=0.02).
CONCLUSIONS: The filter paper technique confirmed increased rectal mucosal release of cytokines and eicosanoids in UC, in proportion to disease activity. The simplicity, safety and speed of the technique make it a practicable option for use in the outpatient clinic to study the pathogenesis of inflammatory bowel disease, and potentially its response to treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716677      PMCID: PMC1727893          DOI: 10.1136/gut.46.4.487

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Rectal mucosal histamine release in ulcerative colitis.

Authors:  D S Rampton; R D Murdoch; G E Sladen
Journal:  Clin Sci (Lond)       Date:  1980-11       Impact factor: 6.124

Review 2.  Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.

Authors:  D S Rampton; C E Collins
Journal:  Aliment Pharmacol Ther       Date:  1993-08       Impact factor: 8.171

3.  Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.

Authors:  C O'Morain; A E Bishop; G P McGregor; A J Levi; S R Bloom; J M Polak; T J Peters
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

4.  Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

Authors:  J Powell-Tuck; D W Day; N A Buckell; J Wadsworth; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

5.  Colonic transport of water and electrolytes in a patient with secretory diarrhea due to collagenous colitis.

Authors:  J Rask-Madsen; O Grove; M G Hansen; K Bukhave; C Scient; R Henrik-Nielsen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

6.  Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.

Authors:  C J Hawkey; F Karmeli; D Rachmilewitz
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

7.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Authors:  P Sharon; M Ligumsky; D Rachmilewitz; U Zor
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

8.  Abnormalities in the apparently normal bowel mucosa in Crohn's disease.

Authors:  M J Goodman; J M Skinner; S C Truelove
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

9.  Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.

Authors:  D S Rampton; G E Sladen; L J Youlten
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  Measurement of prostaglandin E in crevicular fluid.

Authors:  S Offenbacher; D H Farr; J M Goodson
Journal:  J Clin Periodontol       Date:  1981-08       Impact factor: 8.728

View more
  22 in total

Review 1.  Evaluation of new therapies for inflammatory bowel disease.

Authors:  E Carty; D S Rampton
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

2.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 3.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

4.  Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Authors:  Neil D Gross; Jay O Boyle; Jason D Morrow; Myles K Williams; Chaya S Moskowitz; Kotha Subbaramaiah; Andrew J Dannenberg; Anna J Duffield-Lillico
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

5.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

6.  IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway.

Authors:  Rana Al-Sadi; Dongmei Ye; Hamid M Said; Thomas Y Ma
Journal:  Am J Pathol       Date:  2010-11       Impact factor: 4.307

7.  Evaluation of the protective effect of Pterocarpus marsupium on acetic acid-induced ulcerative colitis in rats.

Authors:  Merin Maria Mathew; Nguyen Vinh Han; A Murugesan; E Arun Raj; K G Prasanth
Journal:  Inflammopharmacology       Date:  2015-05-20       Impact factor: 4.473

8.  The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

Authors:  Hilbert S de Vries; Rene H M te Morsche; Martijn G H van Oijen; Iris D Nagtegaal; Wilbert H M Peters; Dirk J de Jong
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

9.  Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis.

Authors:  H-S Kwon; S-M Oh; J-K Kim
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

10.  Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats.

Authors:  Song-Ming Guo; Hong-Bin Tong; Lian-Song Bai; Wei Yang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.